These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28151845)

  • 41. Use of polymerase chain reaction (PCR) in the diagnosis of congenital toxoplasmosis.
    Loveridge-Easther C; Yardley AM; Breidenstein B
    J AAPOS; 2018 Jun; 22(3):239-240. PubMed ID: 29604343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital toxoplasmosis, later relapses and treatment.
    Koppe JG; Meenken C
    Acta Paediatr; 1999 Jun; 88(6):586-8. PubMed ID: 10419236
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiology casebook. Congenital toxoplasmosis: a case report.
    Pan J; Carey BE
    J Perinatol; 1998; 18(6 Pt 1):489-91. PubMed ID: 9848769
    [No Abstract]   [Full Text] [Related]  

  • 44. [Congenital toxoplasmosis with hydrocephalus diagnosed in utero: outcome of treatment].
    Cotty F; Carpentier MA; Descamps P; Perrotin F; Richard-Lenoble D
    Arch Pediatr; 1997 Mar; 4(3):247-50. PubMed ID: 9181018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The child with congenital toxoplasmosis.
    McLeod R; Boyer K; Roizen N; Stein L; Swisher C; Holfels E; Hopkins J; Mack D; Karrison T; Patel D; Pfiffner L; Remington J; Withers S; Meyers S; Aitchison V; Mets M; Rabiah P; Meier P
    Curr Clin Top Infect Dis; 2000; 20():189-208. PubMed ID: 10943525
    [No Abstract]   [Full Text] [Related]  

  • 46. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital toxoplasmosis: therapeutic strategies.
    Foulon W
    Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
    [No Abstract]   [Full Text] [Related]  

  • 48. [Letter: Significance of Toxoplasma infections for public health].
    Koppe JG
    Ned Tijdschr Geneeskd; 1975 Sep; 119(38):1477. PubMed ID: 1165816
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term outcome of children with congenital toxoplasmosis.
    Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
    Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
    Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
    J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
    Couvreur J
    Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
    [No Abstract]   [Full Text] [Related]  

  • 52. Congenital toxoplasmosis: prenatal diagnosis, treatment and postnatal outcome.
    Friedman S; Ford-Jones LE; Toi A; Ryan G; Blaser S; Chitayat D
    Prenat Diagn; 1999 Apr; 19(4):330-3. PubMed ID: 10327137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Congenital toxoplasmosis with unusual retinal findings.
    Brady-McCreery KM; Hussein MA; Paysse EA
    Arch Ophthalmol; 2003 Aug; 121(8):1200-1. PubMed ID: 12912703
    [No Abstract]   [Full Text] [Related]  

  • 55. [Possibilities of preventing and combating congenital toxoplasmosis].
    Arseni C; Ciurea V; Horvath L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1979; 24(4):251-7. PubMed ID: 531389
    [No Abstract]   [Full Text] [Related]  

  • 56. Association between IgG subclasses against Toxoplasma gondii and clinical signs in newborns with congenital toxoplasmosis.
    de Souza-e-Silva CH; Vasconcelos-Santos DV; de Andrade GQ; Carellos EV; de Castro Romanelli RM; de Resende LM; Januário JN; Carneiro M; de Aguiar Vasconcelos Carneiro AC; de Almeida Vitor RW
    Pediatr Infect Dis J; 2013 Jan; 32(1):13-6. PubMed ID: 22935868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cataracts in congenital toxoplasmosis.
    Arun V; Noble AG; Latkany P; Troia RN; Jalbrzikowski J; Kasza K; Karrison T; Cezar S; Sautter M; Greenwald MJ; Mieler W; Mets MB; Alam A; Boyer K; Swisher CN; Roizen N; Rabiah P; Del Monte MA; McLeod R;
    J AAPOS; 2007 Dec; 11(6):551-4. PubMed ID: 18086432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of congenital toxoplasmosis].
    Couvreur J; Desmonts C
    Zentralbl Gynakol; 1983; 105(17):1108-12. PubMed ID: 6650002
    [No Abstract]   [Full Text] [Related]  

  • 60. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.